产业链观察04-29 23:26
#药闻简讯# $Prime Medicine(PRME)$ 公告美国FDA已经批准了该公司于3月29日提交的用于治疗慢性肉芽肿病(CGD)的PM359的IND申请,使该公司能够在美国启动其全球1/2期临床试验。查看全文
狂野飙车的浪子05-04 21:24
回复@有木有措: CCCC调整到位了,近期的价格可以入了。我还持有$Prime Medicine(PRME)$ //@有木有措:回复@狂野飙车的浪子:浪哥,CCCC调整一段了,可以重新入么
查看全文
书白念04-29 19:13
$Prime Medicine(PRME)$ Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)。查看全文
Prime Medicine(PRME)05-10 20:15
$Prime Medicine(PRME)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001628280-24-022466 Act: 34 Size: 239 KB 网页链接查看全文
Prime Medicine(PRME)05-22 04:15
$Prime Medicine(PRME)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001628280-24-024535 Act: 34 Size: 35 KB 网页链接查看全文
Prime Medicine(PRME)05-22 04:15
$Prime Medicine(PRME)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001894562-24-000022 Size: 5 KB 网页链接查看全文
Prime Medicine(PRME)06-13 04:15
$Prime Medicine(PRME)$ 8-K Current report, items 5.03, 5.07, and 9.01 Accession Number: 0001628280-24-027816 Act: 34 Size: 230 KB 网页链接查看全文
JZee2022-10-20 22:49
$全球黄金地段房地产ETF-First Trust Heitman(PRME)$ 基因编辑领域今年最大的金融事件了。看看prime开盘是多少,是个市场的风向标。上市定价是17。查看全文
Prime Medicine(PRME.US)获高盛首次覆盖,给予中性评级,目标价22.00美元。 Prime Medicine(PRME.US)公司简介:Prime Medicine Inc是一家生物技术公司,致力于通过部署基因编辑技术Prime editing提供基因疗法来解决疾病。Prime Editing技术是... 网页链接
$Prime Medicine(PRME)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001894562-24-000035 Size: 5 KB 网页链接
$Prime Medicine(PRME)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001894562-24-000037 Size: 5 KB 网页链接
$Prime Medicine(PRME)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001894562-24-000040 Size: 5 KB 网页链接
$Prime Medicine(PRME)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001894562-24-000039 Size: 5 KB 网页链接
$Prime Medicine(PRME)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001894562-24-000036 Size: 5 KB 网页链接
$Prime Medicine(PRME)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001894562-24-000038 Size: 5 KB 网页链接
$Prime Medicine(PRME)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001894562-24-000041 Size: 5 KB 网页链接
$Prime Medicine(PRME)$ 8-K Current report, items 5.03, 5.07, and 9.01 Accession Number: 0001628280-24-027816 Act: 34 Size: 230 KB 网页链接
$Prime Medicine(PRME)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001894562-24-000026 Size: 8 KB 网页链接
$Prime Medicine(PRME)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001628280-24-024535 Act: 34 Size: 35 KB 网页链接